NCT02358291

Brief Summary

In our study, a multicenter randomized controlled,single blind trial will be performed to evaluate the effectiveness and safety of these three procedures for the treatment of symptomatic lumbar disc herniation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Mar 2015

Typical duration for phase_1

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 6, 2015

Completed
23 days until next milestone

Study Start

First participant enrolled

March 1, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

February 9, 2015

Status Verified

February 1, 2015

Enrollment Period

2 years

First QC Date

January 26, 2015

Last Update Submit

February 6, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Oswestry Disability Index(ODI)

    Oswestry Disability Index (ODI) -\> The Oswestry Disability Index (ODI) is one of the principal condition-specific outcome measures used in the management of spinal disorders. The ODI is the most commonly outcome measures in patients with low back pain. Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. If the FIRST statement is marked, the section score = 0, If the LAST statement is marked, it = 5. 0 is the best outcome and 50 is the worst The ODI is the most commonly outcome measures in patients with low back pain. Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. If the FIRST statement is marked, the section score = 0, If the LAST statement is marked, it = 5. 0 is the best outcome and 50 is the worst outcome

    up to 104 weeks

Secondary Outcomes (3)

  • visual analogue scale(VAS)

    up to 104 weeks

  • The generic health survey on the Short Form-36(SF-36)

    up to 104 weeks

  • Complications survey

    up to 104 weeks

Study Arms (3)

open discectomy

ACTIVE COMPARATOR

patients diagnosed as lumbar disc herniation undergoing open simple discectomy(OD)

Procedure: microendoscopic discectomyProcedure: transforaminal endoscopic lumbar discectomy

microendoscopic discectomy

ACTIVE COMPARATOR

patients diagnosed as lumbar disc herniation undergoing microendoscopic discectomy(MED)

Procedure: open discectomyProcedure: transforaminal endoscopic lumbar discectomy

transforaminal endoscopic discectomy

ACTIVE COMPARATOR

patients diagnosed as lumbar disc herniation undergoing transforaminal endoscopic lumbar discectomy(TELD)

Procedure: open discectomyProcedure: microendoscopic discectomy

Interventions

The open discectomy, will be performed under general anesthesia in the prone position with horizontal. The level of the spine indicated for surgical treatment will be identified with the aid of fluoroscopy. An incision is made about the dorsal disc level involved with dissection of the paravertebral muscles on the side of disc herniation. After laminectomy and resection of part of the yellow ligament, partial discectomy is done under direct vision.

microendoscopic discectomytransforaminal endoscopic discectomy

Microendoscopic discectomy combines standard lumbar microsurgical techniques with endoscope, enabling surgeons to successfully address free-fragment disc pathologic factors and lateral recess stenosis.

open discectomytransforaminal endoscopic discectomy

transforaminal endoscopic lumbar discectomy removes the intervertebral disc portion through the intervertebral foramen

microendoscopic discectomyopen discectomy

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All forms of disc herniation were included in the study
  • History of concordant radicular leg pain refractory to conservative treatment for longer than 6 months
  • Leg pain must be greater than back pain

You may not qualify if:

  • cauda equine syndrome,
  • progressive neurologic deficit,
  • bilateral lower extremity symptoms,
  • low back pain more than leg pain
  • Systemic infection or localized infection at the anticipated entry needle site
  • combined with lumbar infection, fracture of lumbar vertebra, tumor, Ⅱ°and above spondylolisthesis, lumbar spinal stenosis, lumbar scoliosis is larger than 15 degree
  • with severe heart, brain, lungs, and other organs disease or mental illness
  • History of opioid abuse or patients currently on long acting opioid
  • History of the operation on lumbar
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Liu WG, Wu XT, Guo JH, Zhuang SY, Teng GJ. Long-term outcomes of patients with lumbar disc herniation treated with percutaneous discectomy: comparative study with microendoscopic discectomy. Cardiovasc Intervent Radiol. 2010 Aug;33(4):780-6. doi: 10.1007/s00270-009-9720-6. Epub 2009 Oct 15.

  • Wu X, Zhuang S, Mao Z, Chen H. Microendoscopic discectomy for lumbar disc herniation: surgical technique and outcome in 873 consecutive cases. Spine (Phila Pa 1976). 2006 Nov 1;31(23):2689-94. doi: 10.1097/01.brs.0000244615.43199.07.

MeSH Terms

Conditions

Intervertebral Disc Displacement

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Wu Xiaotao, MD

    Zhangda hospital,Southeast university

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Kun Wang

Study Record Dates

First Submitted

January 26, 2015

First Posted

February 6, 2015

Study Start

March 1, 2015

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

February 9, 2015

Record last verified: 2015-02